Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088977900> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W3088977900 abstract "Tofacitinib is an oral disease-modifying anti-rheumatic drug to selectively inhibit Janus kinases. Tofacitinib is a representative small molecule inhibitor that is used to treat many diseases including rheumatoid arthritis and various autoimmune conditions. Unlike biological agents, tofacitinib has several advantages, including the ability to be administered orally and a short half-life. This study aimed to evaluate the bioequivalence of the pharmacokinetics (PK) between tofacitinib aspartate 7.13 mg (test formulation) and tofacitinib citrate 8.08 mg (reference formulation; Xeljanz®) in healthy subjects. A randomized, open-label, single-dose, 2-sequence, 2-period, 2-treatment crossover trial was conducted in 41 healthy volunteers. A total of 5 mg of tofacitinib as the test or the reference formulation was administered, and serial blood samples were collected up to 14 hours after dosing for PK analyses. The plasma concentration of tofacitinib was determined by ultra-performance liquid chromatography-tandem mass spectrometry. A non-compartmental analysis was used to estimate the PK parameters. A total of 35 subjects completed the study and the study drug was well-tolerated. The mean maximum concentration (Cmax) and area under the concentration-time curve from time zero to the time of the last quantifiable concentration (AUClast) for the test formulation were 52.67 ng/mL and 133.86 ng∙h/mL, respectively, and 50.61 ng/mL and 133.49 h∙ng/mL for the reference formulation, respectively. The geometric mean ratios (90% confidence intervals) of the Cmax and AUClast between the 2 formulations were 1.041 (0.944-1.148) and 1.003 (0.968-1.039), respectively. Tofacitinib aspartate exhibited bioequivalent PK profiles to those of the reference formulation.ClinicalTrials.gov Identifier: NCT04278391." @default.
- W3088977900 created "2020-10-01" @default.
- W3088977900 creator A5003765949 @default.
- W3088977900 creator A5012669631 @default.
- W3088977900 creator A5043673816 @default.
- W3088977900 creator A5046565115 @default.
- W3088977900 creator A5050345534 @default.
- W3088977900 creator A5050446339 @default.
- W3088977900 creator A5086609611 @default.
- W3088977900 date "2020-01-01" @default.
- W3088977900 modified "2023-10-16" @default.
- W3088977900 title "Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects" @default.
- W3088977900 cites W1928906432 @default.
- W3088977900 cites W1991688187 @default.
- W3088977900 cites W2001928490 @default.
- W3088977900 cites W2036669253 @default.
- W3088977900 cites W2046503049 @default.
- W3088977900 cites W2065639752 @default.
- W3088977900 cites W2065839099 @default.
- W3088977900 cites W2077502316 @default.
- W3088977900 cites W2120393706 @default.
- W3088977900 cites W2142004396 @default.
- W3088977900 cites W2283215190 @default.
- W3088977900 cites W2296053289 @default.
- W3088977900 cites W2340619566 @default.
- W3088977900 cites W2341245228 @default.
- W3088977900 cites W2411206973 @default.
- W3088977900 cites W2555013571 @default.
- W3088977900 cites W2748996583 @default.
- W3088977900 cites W2766846920 @default.
- W3088977900 cites W2770931697 @default.
- W3088977900 cites W2952528349 @default.
- W3088977900 cites W4210968471 @default.
- W3088977900 doi "https://doi.org/10.12793/tcp.2020.28.e13" @default.
- W3088977900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7533161" @default.
- W3088977900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33062629" @default.
- W3088977900 hasPublicationYear "2020" @default.
- W3088977900 type Work @default.
- W3088977900 sameAs 3088977900 @default.
- W3088977900 citedByCount "1" @default.
- W3088977900 countsByYear W30889779002022 @default.
- W3088977900 crossrefType "journal-article" @default.
- W3088977900 hasAuthorship W3088977900A5003765949 @default.
- W3088977900 hasAuthorship W3088977900A5012669631 @default.
- W3088977900 hasAuthorship W3088977900A5043673816 @default.
- W3088977900 hasAuthorship W3088977900A5046565115 @default.
- W3088977900 hasAuthorship W3088977900A5050345534 @default.
- W3088977900 hasAuthorship W3088977900A5050446339 @default.
- W3088977900 hasAuthorship W3088977900A5086609611 @default.
- W3088977900 hasBestOaLocation W30889779001 @default.
- W3088977900 hasConcept C112705442 @default.
- W3088977900 hasConcept C126322002 @default.
- W3088977900 hasConcept C142724271 @default.
- W3088977900 hasConcept C204787440 @default.
- W3088977900 hasConcept C22979827 @default.
- W3088977900 hasConcept C27081682 @default.
- W3088977900 hasConcept C2776233030 @default.
- W3088977900 hasConcept C2777288759 @default.
- W3088977900 hasConcept C2777575956 @default.
- W3088977900 hasConcept C2778886723 @default.
- W3088977900 hasConcept C42404028 @default.
- W3088977900 hasConcept C71924100 @default.
- W3088977900 hasConcept C87813604 @default.
- W3088977900 hasConcept C98274493 @default.
- W3088977900 hasConceptScore W3088977900C112705442 @default.
- W3088977900 hasConceptScore W3088977900C126322002 @default.
- W3088977900 hasConceptScore W3088977900C142724271 @default.
- W3088977900 hasConceptScore W3088977900C204787440 @default.
- W3088977900 hasConceptScore W3088977900C22979827 @default.
- W3088977900 hasConceptScore W3088977900C27081682 @default.
- W3088977900 hasConceptScore W3088977900C2776233030 @default.
- W3088977900 hasConceptScore W3088977900C2777288759 @default.
- W3088977900 hasConceptScore W3088977900C2777575956 @default.
- W3088977900 hasConceptScore W3088977900C2778886723 @default.
- W3088977900 hasConceptScore W3088977900C42404028 @default.
- W3088977900 hasConceptScore W3088977900C71924100 @default.
- W3088977900 hasConceptScore W3088977900C87813604 @default.
- W3088977900 hasConceptScore W3088977900C98274493 @default.
- W3088977900 hasFunder F4320322657 @default.
- W3088977900 hasLocation W30889779001 @default.
- W3088977900 hasLocation W30889779002 @default.
- W3088977900 hasLocation W30889779003 @default.
- W3088977900 hasOpenAccess W3088977900 @default.
- W3088977900 hasPrimaryLocation W30889779001 @default.
- W3088977900 hasRelatedWork W1012702 @default.
- W3088977900 hasRelatedWork W12002674 @default.
- W3088977900 hasRelatedWork W12515331 @default.
- W3088977900 hasRelatedWork W13726000 @default.
- W3088977900 hasRelatedWork W20514304 @default.
- W3088977900 hasRelatedWork W2949897 @default.
- W3088977900 hasRelatedWork W5590055 @default.
- W3088977900 hasRelatedWork W6773379 @default.
- W3088977900 hasRelatedWork W7569769 @default.
- W3088977900 hasRelatedWork W899728 @default.
- W3088977900 isParatext "false" @default.
- W3088977900 isRetracted "false" @default.
- W3088977900 magId "3088977900" @default.
- W3088977900 workType "article" @default.